3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
11
Prostatic Neoplasms
9
Breast Neoplasms
9
Leukemia, Myeloid, Acute
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Neuroblastoma
6
Myelodysplastic Syndromes
6
Multiple Myeloma
6
Melanoma
6
Lymphoma
6
Glioblastoma
6
Ovarian Neoplasms
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Glioma
4
Osteosarcoma
3
Neoplasm Metastasis
3
Lymphoma, Non-Hodgkin
3
Kidney Neoplasms
3
Fallopian Tube Neoplasms
3
Breast Neoplasms, Male
3
Neoplasms, Plasma Cell
2
Neoplasms
2
Medulloblastoma
2
Hodgkin Disease
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
LY3023414
2
sonidegib
1
sodium thiosulfate
1
ensartinib
1
cixutumumab
1
cabozantinib
1
Restraint, Physical
1
Pharmacogenomic Variants
1
MLN 8237
1
Cyproheptadine
1
Arsenic Trioxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hepatoblastoma
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
No trials found.